Global Sustained-release Enteric Softgel Capsules Market Growth 2025-2031
Description
The global Sustained-release Enteric Softgel Capsules market size is predicted to grow from US$ 846 million in 2025 to US$ 1113 million in 2031; it is expected to grow at a CAGR of 4.7% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Sustained-release Enteric Softgel Capsules are advanced oral drug delivery systems designed to combine controlled-release kinetics with targeted intestinal protection. These capsules utilize a pH-sensitive enteric coating to resist gastric acid degradation, ensuring drug release primarily in the small intestine or colon, while their softgel matrix incorporates sustained-release excipients (e.g., hydrophilic polymers or lipid-based carriers) to prolong drug dissolution over an extended period. This dual-function design enhances bioavailability, minimizes gastrointestinal irritation, and optimizes therapeutic efficacy for drugs sensitive to gastric pH, requiring prolonged action, or targeting specific intestinal absorption sites.
United States market for Sustained-release Enteric Softgel Capsules is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Sustained-release Enteric Softgel Capsules is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Sustained-release Enteric Softgel Capsules is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Sustained-release Enteric Softgel Capsules players cover Catalent, Sirio Pharma, Aenova, ProCaps, InovoBiologic, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Sustained-release Enteric Softgel Capsules Industry Forecast” looks at past sales and reviews total world Sustained-release Enteric Softgel Capsules sales in 2024, providing a comprehensive analysis by region and market sector of projected Sustained-release Enteric Softgel Capsules sales for 2025 through 2031. With Sustained-release Enteric Softgel Capsules sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sustained-release Enteric Softgel Capsules industry.
This Insight Report provides a comprehensive analysis of the global Sustained-release Enteric Softgel Capsules landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Sustained-release Enteric Softgel Capsules portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Sustained-release Enteric Softgel Capsules market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sustained-release Enteric Softgel Capsules and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sustained-release Enteric Softgel Capsules.
This report presents a comprehensive overview, market shares, and growth opportunities of Sustained-release Enteric Softgel Capsules market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Gelatin Type
Vegetable Type
Segmentation by Application:
Supermarket & Hypermarket
Pharmacy & Drug Store
Online Retail
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Catalent
Sirio Pharma
Aenova
ProCaps
InovoBiologic
Alpha
Dart Neuroscience
BASF
Lonza
NutraNorth
Key Questions Addressed in this Report
What is the 10-year outlook for the global Sustained-release Enteric Softgel Capsules market?
What factors are driving Sustained-release Enteric Softgel Capsules market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Sustained-release Enteric Softgel Capsules market opportunities vary by end market size?
How does Sustained-release Enteric Softgel Capsules break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Sustained-release Enteric Softgel Capsules are advanced oral drug delivery systems designed to combine controlled-release kinetics with targeted intestinal protection. These capsules utilize a pH-sensitive enteric coating to resist gastric acid degradation, ensuring drug release primarily in the small intestine or colon, while their softgel matrix incorporates sustained-release excipients (e.g., hydrophilic polymers or lipid-based carriers) to prolong drug dissolution over an extended period. This dual-function design enhances bioavailability, minimizes gastrointestinal irritation, and optimizes therapeutic efficacy for drugs sensitive to gastric pH, requiring prolonged action, or targeting specific intestinal absorption sites.
United States market for Sustained-release Enteric Softgel Capsules is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Sustained-release Enteric Softgel Capsules is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Sustained-release Enteric Softgel Capsules is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Sustained-release Enteric Softgel Capsules players cover Catalent, Sirio Pharma, Aenova, ProCaps, InovoBiologic, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Sustained-release Enteric Softgel Capsules Industry Forecast” looks at past sales and reviews total world Sustained-release Enteric Softgel Capsules sales in 2024, providing a comprehensive analysis by region and market sector of projected Sustained-release Enteric Softgel Capsules sales for 2025 through 2031. With Sustained-release Enteric Softgel Capsules sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sustained-release Enteric Softgel Capsules industry.
This Insight Report provides a comprehensive analysis of the global Sustained-release Enteric Softgel Capsules landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Sustained-release Enteric Softgel Capsules portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Sustained-release Enteric Softgel Capsules market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sustained-release Enteric Softgel Capsules and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sustained-release Enteric Softgel Capsules.
This report presents a comprehensive overview, market shares, and growth opportunities of Sustained-release Enteric Softgel Capsules market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Gelatin Type
Vegetable Type
Segmentation by Application:
Supermarket & Hypermarket
Pharmacy & Drug Store
Online Retail
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Catalent
Sirio Pharma
Aenova
ProCaps
InovoBiologic
Alpha
Dart Neuroscience
BASF
Lonza
NutraNorth
Key Questions Addressed in this Report
What is the 10-year outlook for the global Sustained-release Enteric Softgel Capsules market?
What factors are driving Sustained-release Enteric Softgel Capsules market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Sustained-release Enteric Softgel Capsules market opportunities vary by end market size?
How does Sustained-release Enteric Softgel Capsules break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
94 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Sustained-release Enteric Softgel Capsules by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Sustained-release Enteric Softgel Capsules by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
